Morita, Shuhei
Villalta, S. Armando
Feldman, Hannah C.
Register, Ames C.
Rosenthal, Wendy
Hoffmann-Petersen, Ingeborg T.
Mehdizadeh, Morvarid
Ghosh, Rajarshi
Wang, Likun
Colon-Negron, Kevin
Meza-Acevedo, Rosa
Backes, Bradley J.
Maly, Dustin J.
Bluestone, Jeffrey A.
Papa, Feroz R.
Funding for this research was provided by:
NIH (RO1DK080955, RO1GM086858, RO1AI046643, RO1DK100623, P30 DK063720, T32GM008268)
Burroughs Wellcome Fund
JDRF (17-2013-513, 3-PDF-2015-80-A-N, 2-SRA-2016-234-S-N)
Sumitomo Life Social Welfare Sciences Foundation
Lundbeck Foundation Clinical Research Fellowship Program
Brehm Coalition
Breakthrough Therapeutics Initiative from Leona M. and Harry B. Helmsley Charitable Trust
This article is maintained by: Elsevier
Article Title: Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune Diabetes
Journal Title: Cell Metabolism
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.cmet.2017.03.018
Content Type: article
Copyright: © 2017 Elsevier Inc.